News on in vitro diagnostics for gastrointestinal disease.

Researchers hope that understanding the etiology of inappropriate testing will help them design a better computerized support tool.

The spinout of the University of California, Davis Foods For Health Institute intends the test to be used at the point of care in pediatrician's offices.

The companies aim to develop microbiome diagnostic assays for colon cancer and other gastrointestinal diseases including irritable bowel syndrome.

The assay can be used in conjunction with other laboratory and clinical findings to differentiate IBD from irritable bowel syndrome, the firm said.